logo
Product categories

EbookNice.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link.  https://ebooknice.com/page/post?id=faq


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookNice Team

(Ebook) Combined Estrogen-Progestogen Contraceptives and Combined Estrogen-Progestogen Menopausal Therapy (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans : Volume 91) by International Agency for Research on Cancer ISBN 9789240683211, 9789283212911, 9240683216, 9283212916

  • SKU: EBN-1888934
Zoomable Image
$ 32 $ 40 (-20%)

Status:

Available

0.0

0 reviews
Instant download (eBook) Combined Estrogen-Progestogen Contraceptives and Combined Estrogen-Progestogen Menopausal Therapy (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans : Volume 91) after payment.
Authors:International Agency for Research on Cancer
Pages:537 pages.
Year:2008
Editon:1
Language:english
File Size:2.62 MB
Format:pdf
ISBNS:9789240683211, 9789283212911, 9240683216, 9283212916
Categories: Ebooks

Product desciption

(Ebook) Combined Estrogen-Progestogen Contraceptives and Combined Estrogen-Progestogen Menopausal Therapy (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans : Volume 91) by International Agency for Research on Cancer ISBN 9789240683211, 9789283212911, 9240683216, 9283212916

This ninety-first volume of IARC Monographs contains evaluations of the carcinogenic hazard to humans of combined estrogen-progestogen contraceptives and combined estrogen-protestogen menopausal therapy. The hormonal drugs reviewed in this volume involve co-administration of an estrogen and a progestogen. Studies that did not provide information on the use of combined estrogen-progestogen agents are not reviewed. It should also be noted that this volume reviews only studies that are publicly available and therefore does not include pharmaceutical test results that are not in the public domain.
*Free conversion of into popular formats such as PDF, DOCX, DOC, AZW, EPUB, and MOBI after payment.

Related Products